PTR manifested in 30.4% (28/92) of the patients who had CBF‐AML, in contrast to 8.1% (38/468) of the others, indicating a strong correlation between PTR and CBF‐AML (P < .001, Figure 1A, Figure S2A,B). Here, CEBPZ is linked to acute myeloid leukemia.